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Abstract 
 Neisseria gonorrhoeae, the causative agent of the sexually transmitted infection 
gonorrhea, has developed resistance to every antimicrobial used against it. Ceftriaxone-
resistant N. gonorrhoeae strains harbor mosaic penA alleles that encode highly mutated forms 
of Penicillin-Binding Protein 2 (PBP2), the lethal target of ceftriaxone. When bacteria develop 
resistance to antibiotics through an extensive alteration of an essential protein, they often incur 
a fitness cost. To have success as a pathogen, they must overcome this fitness deficit. We have 
hypothesized that antibiotic-resistant clinical isolates acquire compensatory mutations to help 
alleviate the fitness cost associated with resistance. Wild-type strains harboring a mosaic penA 
allele have reduced fitness both in vitro and in vivo, but compensatory mutants with increased 
biological fitness were isolated. In one such strain, a mutation (G348D) in acnB, which encodes 
the tricarboxylic acid (TCA) cycle aconitase, was identified. The hallmark of this compensatory 
mutant is that it grows rapidly during log-phase growth, but then plateaus early as it enters into 
stationary phase growth. The acnB-G348D mutation is both necessary and sufficient to impart 
the growth phenotype characteristic of compensatory mutant. Western blots of AcnB during the 
growth cycle show that wild-type AcnB increases in abundance as the cells enter stationary 
phase, whereas in the AcnB mutant, expression decreases by 2- to 3- fold. Interestingly, acnB 
mRNA levels do not account for changes in AcnB protein levels.  These data suggest that acnB-
G348D acts as a functional knockout in regards to the role of AcnB in the TCA cycle. Any fitness 
benefits associated with this mutation do not appear to be directly associated with the activity of 




Neisseria gonorrhoeae, the causative agent of the sexually transmitted infection 
gonorrhea, is the second most common STI in the United States, with 350,062 cases reported 
by the CDC in 2014 (an increase of 10.5% since 2010).  Since N. gonorrhoeae infections are 
often asymptomatic in women, they can go untreated, leading to further dissemination of the 
infection and to a variety of sequelae, including pelvic inflammatory disease (PID) and ectopic 
pregnancy. There is also evidence that a gonococcal infection can increase the risk of both 
acquiring and transmitting HIV [1] [2]. Unfortunately, N. gonorrhoeae has become resistant to 
essentially all antibiotics used to treat infections. The emergence of fluoroquinolone-resistant 
strains in the United States in 2007 caused the CDC to remove fluorquinolones from treatment 
guidelines, leaving only ceftriaxone and cefixime, and in 2010 the CDC removed cefixime from 
the list of recommended antibiotics. In 2015, the guidelines were changed to a dual therapy of 
ceftriaxone and azithromycin. Worryingly, multiple strains with high-level resistance to either 
ceftriaxone or azithromycin were identified internationally during that period [3]. 
Ceftriaxone-resistant isolates have been shown to contain mosaic penA alleles encoding 
a highly mutated Penicillin-Binding Protein 2 (PBP2). PBP2 is an essential peptidoglycan 
transpeptidase during cell wall synthesis in bacteria and is the lethal target of β-lactam 
antibiotics such as ceftriaxone and penicillin [4]. Although the mutations in the mosaic penA 
alleles contribute to increased resistance, they also confer a biological fitness cost thought to be 
due to the reduced peptidoglycan transpeptidase activity of PBP2 caused by the mutations. 
Preliminary experiments using the female model of infection have shown that a wild-type 
gonococcal strain, FA19, carrying the mosaic penA41 allele from the ceftriaxone-resistant strain 
H041 also have a significant biological fitness deficit. Our collaborators in the Jerse lab had 
previously shown that N. gonorrhoeae can acquire spontaneous compensatory mutations in the 
host to overcome the biological fitness cost of fluoroquinolone-resistant alleles [5]. Consistent 
with this, several isolates of FA19 penA41 harboring compensatory mutations were isolated 
from infected mice that increased fitness without decreasing resistance. One of these strains, 
LV41C, contained a point mutation the acnB gene (coding for the TCA cycle enzyme, aconitase) 
causing an amino acid change from a glycine to aspartic acid at position 348. My research 
project was focused investigating the mechanisms by which this mutation helps compensate for 
the biological fitness deficit caused by the penA41 allele. 
In many species, the cost of carrying a resistance allele is associated with an increased 
metabolic stress, either directly through increased transcription, translation, and/or DNA 
replication, or more indirectly through an induction of altered physiology and metabolism of the 
bacterium. In vitro experiments with amoxicillin-resistant strains of E. coli showed that upon 
initial acquisition of the resistance allele, the strains had an increased metabolic cost when 
compared to the parental strain; however, subsequent generations experienced a decreased 
metabolic cost when compared to the initial resistant strain [6]. Other studies have shown that 
the exact cost of a resistance allele is extremely variable and dependent on the specific species 
and genotype [7].  It is important to note that the mechanisms used to overcome fitness costs in 
vitro may result in a decreased fitness in vivo because the metabolic environment is often very 
different in vitro than in vivo [8]. With clinical isolates of drug-resistant Mycobacterium 
tuberculosis, it was observed that only strains with a relatively high fitness were isolated, and 
fitness may determine the future evolution of multidrug-resistant strains [9]. 
 Metabolism in N. gonorrhoeae is very streamlined and suited to conditions in vivo. The 
vaginal tract is the primary site of gonococcal infections and the two main carbon sources 
present in the vaginal cavity are glucose and lactate (as lactic acid). Although the amount of free 
glucose is limited, glycogen is readily supplied by the vaginal epithelia and subsequently broken 
down by resident flora or enzymes present in the vaginal tract into free glucose, or further 
degraded by the vaginal flora into lactic acid [3] [10]. N. gonorrhoeae can effectively utilize only 
glucose, lactate, or pyruvate as a carbon source [11], but pyruvate does not appear to be 
biologically relevant. The gonococcus also has a variety of unusual alterations in metabolism, 
namely a non-functional TCA cycle during active growth on glucose [12]. Aconitase and 
isocitrate dehydrogenase, most classically defined as “essential” enzymes for aerobic 
organisms, are inactive during active growth in glucose, and the gonococcus instead uses 
glutamate and the enzyme PEP carboxylase to generate α-ketoglutarate and oxaloacetate, 
respectively [12]. In other species, such as E. coli, the presence of large quantities of glucose 
can repress the TCA cycle in order to streamline metabolism [13]. The adaptation of N. 
gonorrhoeae to such a glucose-rich environment may explain why the TCA cycle is 
downregulated. Paradoxically, despite not having a functional TCA cycle during active growth 
on glucose, the gonococcus utilizes the Entner-Doudoroff pathway for glycolysis, which is half 
as efficient as the Embden-Meyerhof-Parnas pathway as it only generates 1 net ATP and 1 net 
reduced pyridine nucleotide per molecule of glucose [11]. Other unusual alterations in 
metabolism include pyridine nucleotide-independent lactic acid dehydrogenases, which may 
help with lactate acquisition, and a NAD+/NADP+ non-specific glucose-6-phosphate 
dehydrogenase [14] [12]. 
 Here we present evidence demonstrating that wild-type strains carrying the penA41 
allele from the ceftriaxone-resistant strain H041 have a significant biological fitness deficit. We 
have also demonstrated that strains can overcome this deficit by acquiring spontaneous 
compensatory mutations. One of the mutants identified contained a mutation (acnB-G348D) in 
the gene encoding the TCA cycle enzyme aconitase. Because antibiotic resistance alleles can 
impose a biological fitness deficit through the form of an increased metabolic stress and this 
compensatory mutation is in a metabolism gene, we have reason to suspect that this mutation 
may be altering the metabolism of N. gonorrhoeae either directly or indirectly, and ameliorating 
the metabolic stress on the organism. My project focused on elucidating the mechanism(s) by 




 N. gonorrhoeae strains were grown in liquid GCB media or on GCB agar plates at 37oC 
with Supplements I (glucose, glutamine, and cocarboxylase) and II (12 µM Fe(NO3)3) [15]. Agar 
plates were grown under 4% CO2 whereas liquid media was supplemented with 10 mM 
NaHCO3. Media containing lactate as the carbon source instead of glucose was made by 
substituting sodium lactate at a 1:1 molar ratio for glucose in Supplement I at pH 7.0. E. coli 
strains were grown in liquid LB media or on LB agar plates at 37 oC. 
  
2. Growth Curves 
 N. gonorrhoeae strains were streaked from frozen stocks onto GCB agar plates 
containing the appropriate carbon source and incubated overnight at 37°C in a humidified 4% 
CO2 incubator. Non-piliated colonies were selected, plated and the bacteria were swabbed after 
17h of growth and used to inoculate liquid GCB media to give a starting OD600 of 0.08.  N. 
gonorrhoeae liquid cultures were grown for 8 hours in a T75 flask in a shaking incubator set at 
37°C and 170-200 RPM. Samples were removed each hour for the determination of optical 
density (OD600), Western blot analysis, aconitase assays and real-time RT-/qPCR experiments 
as described below. Growth curves where strains never exited lag phase were not included and 
each experiment was repeated in at least triplicate unless otherwise noted. The arithmetic mean 
± standard error is displayed unless otherwise noted. 
E. coli samples DH5α cells were streaked from plates stored at 4°C onto LB agar plates 
and grown overnight at 37°C. Cells were swabbed and used to inoculate liquid LB media to give 
a starting OD600 of 0.08. E. coli liquid cultures were grown for 8 hours in a baffled 250mL 
Erlenmeyer flask. Samples were removed every other hour for determining optical density 
(OD600) and after 8 hours (in stationary phase) samples were taken for aconitase activity assays 
as described below. 
 
3. Glucose Measurement 
 The glucose concentration of the media was measured at each time point using a Bayer 
Contour Next blood glucose monitor. A standard curve was generated using GCB liquid media 
with known concentrations of glucose to account for differences in conductivity between blood 
and GCB media. 
 
4. RNA Extraction, RT-PCR and qPCR 
 The appropriate strains were grown in liquid GCB media with glucose as the carbon 
source. The equivalent of 10 mL of cells at OD600 0.18 was removed at 2 and 3 hr (log phase) 
and at 7 and 8 hr (stationary phase) of growth, the bacteria were collected by centrifugation, re-
suspended in RNAlater, and stored at 4°C. Total RNA from the cells was extracted the next day 
using the Bio-Rad Aurum Total RNA Mini Kit and eluted in 40µL RNase-free water. One µL of 
RNAsin (RNase inhibitor, Promega) was added to the extracted RNA and the total RNA 
concentration was determined using a Nanodrop reader. To remove any DNA contamination, 1 
µg of total RNA was digested for approximately 40 minutes at 37°C with 1 unit of RQ1 RNase-
free DNase (Promega). The DNase was inactivated using the supplied stop solution at 65°C for 
10 minutes. 
 cDNA was generated from purified total RNA using the Bio-Rad iScript Reverse 
Transcription Supermix. Real-time qPCR was performed using the Bio-Rad Sso Advanced 
Universal SYBR Green Supermix, the oligonucleotides listed in Table 1, and the Bio-Rad 
CFX96 Touch Real-Time PCR Detection System. Fold change was determined using the 2!∆∆!! 
method [16] with 16S rRNA as the reference gene. RNA reference samples were diluted 
1:50,000 using RNase-free water. 
 
5. Western Blotting and Electrophoresis 
 Aliquots of N. gonorrhoeae liquid cultures were taken hourly starting at 2 hours of 
growth. The equivalent of 1 mL of cells at OD600 = 0.18 (i.e. 0.18 OD•mL) was pelleted, the 
supernatant was aspirated, and the samples were frozen at -20°C if not used immediately. 
Pellets were re-suspended in 100 µL fresh 1X Sample Buffer (0.07M Tris-HCl, pH 6.8, 10% 
Glycerol, 5% beta-mercaptoethanol, 1.05% SDS, dyed with Bromophenol Blue) and boiled for 5 
minutes. Samples were centrifuged briefly and equal volumes of protein were loaded and 
resolved on a 10% polyacrylamide SDS-PAGE gel. 
 The proteins in the gel were transferred to a PVDF membrane and blocked in PBS-
Tween (PBS with 0.1% Tween 100) containing 5% non-fat dry milk (NFDM) for 1 hour at room 
temperature on a shaker table. The membrane was incubated in PBS-Tween containing 2.5% 
NFDM and 1:10,000 rabbit PilM antibody for 1 hour at room temperature on a shaker table. The 
membrane was then washed four times for 9 minutes each in fresh PBS-Tween on a shaker 
table. The membrane was then incubated in PBS-Tween containing 2.5% NFDM, 1:1,000 3F10 
(mouse HA antibody conjugated with HRP) and 1:20,000 goat anti-rabbit HRP-conjugated 
antibody for 1 hour at room temperature on a shaker table. The membrane was washed again 
as previously described and then incubated for 2 minutes with Bio-Rad ECL reagents and 
photographed using the Bio-Rad ChemiDoc Touch Imager. PilM was used as an internal 
loading control because its production does not appear to change in different phases of growth, 
however it was not used to normalize protein abundance between strains because its 
abundance appears to vary between strains. 
  
6. Aconitase Activity Assays 
 
 Samples were prepared in a similar manner as described by Gardner [17] and 
Hausladen and Fridovich [18]. Strains were grown in liquid cultures with glucose as the carbon 
source as previously described until they reached an OD600 0.5 or until they had reached 
stationary phase (8 hours), at which point 10 OD•mL of cells were collected by centrifugation, 
re-suspended in 1 mL of Tris/BME Buffer (0.4M Tris-HCl pH 7.4, 5mM beta-mercaptoethanol) 
and pelleted again. Pellets were re-suspended again in 200µL of new Tri-BME, snap frozen in a 
dry ice bath and stored at -80°C for later use. Samples were thawed in RT water and snap 
frozen/thawed one more time for a total of two freeze/thaw cycles. Samples were then sonicated 
in an ice bath using a VirSonic 50 ultrasonic probe sonicator at 50% power for 6 15-sec pulses 
with 20-sec pauses between sonications. Samples were then snap frozen/thawed for an 
addition cycle and then spun in a TL-100 benchtop ultracentrifuge for 20 min at 40k rpm. The 
clear, soluble fraction of the lysate was removed to a clean tube and stored at -80°C for later 
use. FA19 samples were prepared from at least 2 biological replicates. 
Aliquots of lysate were either treated with dipyridyl, reactivated, or left untreated. For 
dipriydyl treatment, 45µL of lysate was mixed with 6µL dipyridyl buffer (4.25mM dipyridyl, 
5.525mM dextrose in water) and incubated on ice for 1 hr. Dipyridyl is a non-ionic iron chelator 
that inactivates aconitases [17]. For reactivation, 45µL of lysate was placed in a screw-capped 
tube, supplemented with 5µL 0.5M DTT, 0.5µL 20mM Na2S and 0.5µL 20mM (NH4)2Fe(SO4)2, 
then placed under nitrogen, sealed with parafilm and incubated on ice for 30min. For untreated 
samples, 45µL of lysate was mixed with 6µL of dH2O before being assayed.  
The activity assays were performed quickly, particularly with reactivated samples, so that 
minimal aconitase activity was lost upon exposure to oxygen. First, 90µL of dH2O was added to 
each well, then 10µL of lysate was added to the appropriate wells in a microtiter plate before 
200µL of reaction mix was quickly added using a repeater pipette for a total volume of 300µL 
(Final Concentration: 50mM Tris-HCl (pH 7.4), 0.6mM MnCl2, 0.2mM NADP+, 20mM Sodium 
Citrate, 18µg/mL IDH). The linear increase in absorbance at 340nm during the first ~3.5 minutes 
of the reaction was measured and the molar extinction coefficient of NADPH (6.22 x103 M-1cm-1) 
was used to calculate the amount of aconitase activity present. One unit of aconitase activity 
was defined as the generation of one µmole of NADPH per minute. 
Protein concentration was determined using a modified Bio-Rad Bradford Protein Assay. 
Two, four, six, and eight µL of diluted samples and BSA standards were mixed with 40µL Bio-
Rad Bradford Reagent and dH2O to a final volume of 200µL in a microtiter plate. The plate was 
left to incubate at RT for 10 min and then the OD595 was measured. The ratio of the slopes 
between the BSA standard and the diluted protein samples was used to calculate the protein 
concentration of the samples.  
For purified protein assays, the mutant and wild-type versions of the N. gonorrhoeae 
acnB gene were cloned into E. coli, overexpressed and purified. Immediately before 
measurement, the proteins were re-activated using Na2S, Fe2+, and DTT and kept under 
nitrogen prior to use. AcnB activity was measured by adding citrate or isocitrate and monitoring 
the formation of cis-aconitate at 240 nm. Aconitase activity assays on purified protein were 
performed by Josh Tomberg. 
 
7. RNA Synthesis 
The 5’ UTR and extended 3 ’UTR of the acnB mRNA from N. gonorrhoeae FA19 were 
cloned into the BamHI and XbaI sites next to the T7 promoter of pBSII KS+. The 5’UTR of acnB 
was defined as the region from -76 to +277. The extended 3’UTR was defined as from 28 bases 
upstream of the acnB stop codon to 295 bases downstream of the acnB stop codon. Plasmids 
were transformed into E. coli MC1061 cells and were purified using the Invitrogen Plasmid 
Miniprep Kit. Purified plasmids were linearized with BamHI and the RNA was transcribed using 
the NEB HiScribe T7 In Vitro Transcription Kit. Transcripts were purified using the Qiagen 
RNeasy Mini Kit and 1 µL of RNAsin (RNase inhibitor, Promega) was added per 40µL of 
recovered RNA. RNA quality was qualitatively confirmed by running the transcripts and supplied 
positive control on a 1% agarose TAE gel. The RNA concentration was found using a Nanodrop 
reader. The cloned tssA1 RNA from Pseudomonas aeruginosa from Marden et al. [19] was 
used as the RNA in the positive control with RsmA protein for the EMSAs. 
 
8. Electrophoretic Motility Shift Assays (EMSAs) 
AcnB purified protein was inactivated by incubating the enzyme with a 50-fold molar 
excess of EDTA and 20-fold molar excess of Potassium Ferricyanide for 6 minutes on ice. The 
inactivated AcnB protein (Apo-AcnB) was purified again using size-exclusion chromatography. 
The RsmA protein from P. aeruginosa from Marden et al. [19] was used as the positive control 
protein with tssa1 RNA transcribed in vitro. 
An EMSA was set up so that 70ng of RNA was incubated with various amounts of 
protein (see Figures 12 and 13) in 10mM Tris-Cl (pH 7.5), 10mM MgCl2, 100mM KCl, 5% 
glycerol, 10mM DTT, and 0.25µL RNasin to a final volume of 10µL and incubated at 37°C for 30 
min. The mixture was then supplemented with 2µL 6X Invitrogen (EMSA) gel-loading solution 
and immediately loaded onto a non-denaturing 5% polyacrylamide gel and resolved. The 
running buffer (10mM Tris-Cl, 300mM Glycine, 1mM EDTA) was prepared ahead of time and 
stored at 4°C. The gel was also pre-run at 200V for 30 minutes and the gel apparatus was kept 
in an ice bath to keep it cold. 
The finished gel was then incubated with 1X SYBR Green (Nucleic Acid Dye) in 1X TBE 
buffer in the dark for 30 minutes, washed three times for 10 seconds with dH2O and imaged 
using the Bio-Rad ChemiDoc Touch Imager. The same gel was then incubated in SYPRO Ruby 
(Protein) Stain for 3 hours in the dark, washed three times for 10 seconds with dH2O, destained 
with 10% methanol/7% acetic acid for one hour, washed three times for 10 seconds with dH2O 
again and then imaged using the Bio-Rad ChemiDoc Touch Imager. 
  
Results 
1. Growth Phenotypes 
 Five strains were examined for their growth phenotypes: FA19 rpsL, FA19 rpsL penA41, 
FA19 rpsL acnB-G348D, FA19 rpsL penA41 acnB-G348D, and the compensatory mutant strain 
LV41C (Figure 1). The rpsL gene confers streptomycin resistance and is necessary for 
colonization in the mouse model of gonococcal infection [20]. Importantly, the two strains 
containing the acnB-G348D mutation, FA19 rpsL penA41 acnB-G348D and FA19 rpsL acnB-
G348D, mirrored the growth phenotype of LV41C. These strains demonstrated an increased 
growth rate during log phase as compared to FA19 rpsL penA41 and a lower OD600 in stationary 
phase as compared to FA19 rpsL and FA19 rpsL penA41. After entering stationary phase, both 
acnB-G348D strains experienced a slight decrease in OD600 (Figure 1). Strains containing the 
acnB-G348D mutation also had an increased growth rate during log phase and decreased 
OD600 in stationary phase relative to FA19 rpsL and FA19 rpsL penA41 when grown in media 
containing lactate instead of glucose; however, the overall growth rate of all strains was reduced 
(Figure 2). These data indicate that introduction of the acnB-G348D mutation is both necessary 
and sufficient to phenocopy the growth characteristics of the original spontaneous 
compensatory mutant LV41C. 
  
2. Glucose Consumption 
 Since detectable levels of aconitase activity in N. gonorrhoeae have been reported to be 
present only when glucose has been depleted [12], the glucose consumption during liquid 
growth was determined for three strains, FA19 rpsL, FA19 rpsL penA41 acnB::kan, and LV41C 
(Figure 3). Glucose levels remained relatively stable for about 3 hours, then showed a linear 
decline to 10-15 mM at the end of 8 hrs, and there were no noticeable changes in glucose 
consumption when transitioning from log phase to stationary phase. Neither FA19 rpsL penA41 
acnB::kan nor LV41C showed any difference in the pattern of glucose consumption compared to 
FA19 rpsL. There was no complete glucose depletion observed, even after 8 hours of growth 
(Figure 3). 
 
3. Relative AcnB Protein Abundance 
The report that AcnB activity was only present in glucose-depleted conditions in N. 
gonorrhoeae suggested a complex, phase-dependent regulation of AcnB; therefore, I assessed 
AcnB protein production throughout the growth cycle. Equal amounts of OD•mL from strains 
producing HA-tagged AcnB, FA19 rpsL acnB-HA, FA19 rpsL acnB-G348D-HA, FA19 rpsL 
penA41 acnB-HA and FA19 rpsL penA41 acnB-HA, were sampled hourly starting at the 
beginning of logarithmic growth (t=2 hr) and ending at stationary phase growth (t=8 hr) and 
prepared for SDS-PAGE Following electrophoresis, the separated proteins were transferred to 
PVDF membranes and blotted with 3F10 antibody to identify HA-tagged proteins. Strains 
producing the AcnB-G348D mutant had a 5- to 10-fold decrease in AcnB protein production 
compared to those containing an HA-tagged wild-type AcnB at t=2 hr. The addition of the 
penA41 allele alone did not significantly alter the amount of AcnB protein compared to the strain 
with wild-type acnB gene (Figure 4). When the levels of WT and mutant AcnB were normalized 
to the levels at t=2 hr of growth, strains FA19 rpsL acnB-HA and FA19 rpsL acnB-G348D-HA 
showed consistent AcnB abundance throughout log phase growth, but as the strains 
transitioned into stationary phase, the wild-type AcnB protein abundance increased 2- to 3-fold, 
whereas the mutant AcnB abundance decreased 2- to 3-fold (Figure 5). 
 The addition of the penA41 allele in strains with the wild-type acnB gene did not appear 
to prevent the increase of AcnB protein from log to stationary phase. The effect of the penA41 
allele in strains with a mutant acnB gene was indeterminate (Figure 6). 
  
4. Relative acnB mRNA Expression 
 In other species, AcnB is known to bind to its own transcript to regulate the translation 
and degradation of its own message [21]. To determine if the variations in protein abundance 
during in vitro growth (Figure 5) could be explained by differences in mRNA levels, RT/qPCR 
was performed on total RNA isolated cells from cells harvested from log phase (t=2, 3) and 
stationary phase (t=7, 8) growth. There was no change in acnB mRNA expression observed 
between log phase growth and stationary phase growth in strains expressing either the wild-
type or mutant acnB gene (Figure 7, 8). Compared to the wild-type acnB strain, the mutant 
strain had just over a 2-fold increase in acnB mRNA in both stationary and log phases of growth 
(Figure 9). 
 
5. Aconitase Activity 
To ascertain the effect of the G348D mutation on the aconitase activity of the enzyme 
itself, we measured the formation of cis-aconitate from either citrate or isocitrate by quantifying 
the increase in absorbance at 240 nm. The initial rates of aconitate formation were plotted at 
different citrate or isocitrate concentrations, and the Vmax and Km constants were derived 
(Figure 10, experiment performed by Josh Tomberg). The mutant AcnB protein showed a 2.6-
fold reduction of the Vmax in the direction of citrate à cis-aconitate and a 3.2-fold reduction of 
the Vmax in the direction isocitrate à cis-aconitate compared to the wild-type protein. 
I also determined the amount of aconitase activity present in cell lysates of liquid 
cultures of FA19 rpsL harvested at log phase and stationary phase growth. I measured the 
amount of citrate converted to isocitrate indirectly by quantifying the increase in absorbance at 
340nm due reduction of NADP+ to NADPH by isocitrate dehydrogenase in samples 
supplemented with citrate and excess isocitrate dehydrogenase. There was approximately 7.5 
mU of aconitase activity/mg of soluble protein (95% CI 5.7-9.3 mU/mg) in log phase-reactivated 
FA19 rpsL lysates and 7.0 mU/mg of activity (95% CI 6.4-7.6 mU/mg) in stationary phase-
reactivated FA19 rpsL lysates. There was minimal or no aconitase activity detected in FA19 
lysates that were not reactived or were dipyridyl-treated. For reference, reactivated stationary 
phase E. coli lysates had 39.7 mU/mg of activity (95% CI 36.6-42.9 mU/mg) and in unactivated 
and dipyridyl-treated lysates there was approximately 2.7 and 1.9 mU/mg of activity, 
respectively (Figure 11). There was no difference in aconitase activity detected in reactivated 
samples (i.e. treated with Na2S, Fe2+, and dithiothreitol) from log and stationary phase samples 
of FA19 rpsL liquid cultures and all aconitase activity was lost in processed samples that were 
not reacitvated. Overall, E. coli liquid cultures exhibited more than 5-fold more aconitase activity 
per mg of soluble protein than FA19 rpsL liquid cultures. 
 
6. EMSA 
 In other species, aconitase can function as a posttranscriptional regulator by binding to 
the 5’ or 3’ UTRs of mRNAs, including its own mRNA [21] [22]. To ascertain if there was any 
binding between acnB mRNA and AcnB protein that could explain the relationship between 
protein abundance and mRNA expression, electrophoretic motility shift assays were performed 
using the 5’ and 3’ UTRs of acnB mRNA and apo-AcnB protein. Apo-AcnB was used because 
the apo-enzyme state is necessary for mRNA binding in other aconitases [21]. We detected no 
observable shift or overlap in RNA and/or protein (Figures 12 and 13), although there was 
overlap in the positive control protein, RsmA, and its binding mRNA, tssa1, along with a shift in 
both the RsmA protein and tssa1 mRNA bands. These data suggest there was no binding 
detected between either the 5’ UTR or 3’ UTR of acnB mRNA and Apo-AcnB protein. Future 
experiments will be necessary to determine unequivocally if apo-AcnB can bind to acnB mRNA. 
  
Discussion 
1. Growth Phenotype 
 The stationary phase of bacterial growth is often caused by depletion of resources below 
a threshold or by signaling molecules from other bacteria that indicate a bacterial population has 
reached critical density. Usually, exhaustion below a relative threshold of only one essential 
nutrient is sufficient for stationary phase to occur [23]. Pyruvate, lactate, and glucose are the 
only 3 carbon sources that can be efficiently utilized by N. gonorrhoeae, with the latter two being 
the only ones that are common and readily available in vaginal fluid [24] [10]. Previous studies 
have shown that N. gonorrhoeae undergoes a metabolic shift after the depletion of glucose, 
which might be classically associated with stationary phase [12]. In these experiments, there 
was no complete depletion of glucose as the bacteria entered stationary phase for any strain, 
suggesting that the stationary phase was not caused by a total depletion of glucose. However, 
our data do not rule out that entrance into stationary phase was initiated when glucose levels, 
while not absent, dropped below a certain threshold. Similarly, since lactate did not alter the 
growth phenotype in acnB mutants, the availability of different carbon sources did not appear to 
influence the growth phenotypes. 
 
 
2. Function of AcnB as a TCA enzyme in N. gonorrhoeae 
E. coli has at least two functional aconitases, AcnA and AcnB [21]. AcnB is the primary 
aconitase enzyme during logarithmic growth, whereas the more oxidatively stable AcnA is 
produced during stationary growth. In N. gonorrhoeae, the acnA gene contains a frameshift 
mutation that generates a premature stop codon. This protein is not produced at any observable 
levels and, even after the gene is repaired and placed under a promoter that should allow AcnA 
to be constitutively produced, production of the AcnA protein is not observed (data not shown; 
experiments performed by Josh Tomberg). Thus, AcnB is the only known functional aconitase in 
N. gonorrhoeae. 
Interestingly, the early entrance into stationary phase growth and even the slight decline 
in OD600 is a direct consequence of the marked decrease of aconitase activity. In N. 
gonorrhoeae, aconitase activity has been reported to become active once acetate in the 
medium is imported, converted to acetyl-CoA, and then condensed with oxaloacetate to 
generate citrate. Because strains containing the acnB-G348D mutation have i) a 5- to 10-fold 
reduction in abundance in log phase, ii) a 30- to 80-fold reduction in abundance in stationary 
phase, and iii) a 3-fold reduction in activity relative to strains producing wild-type AcnB, it would 
appear that the acnB-G348D mutation acts as a functional knockout with regards to the activity 
of AcnB in the TCA cycle. The absence of production of AcnB-G348D in stationary phase and 
the lower activity of AcnB-G348D in enzymatic assays suggest that the stationary phase levels 
of aconitase activity in the mutant are severely decreased, which is consistent with the growth 
phenotype of strains harboring the mutant acnB allele. It is reasonable to conclude that upon 
entering stationary phase, the wild-type AcnB protein is up-regulated in order to maximize 
energy generation and therefore increases the number of cells that can be sustained in 
stationary phase, thus leading to a difference in OD600 in stationary phase compared to mutant 
strains. Although the activity assays did not show a significant difference in aconitase activity 
between log phase and stationary phase, it is possible that the assay is not sensitive enough to 
detect the difference between log and stationary phase activity, or more likely that normally 
inactive protein is reactivated by the assay procedure. The lack of detail in the methods section 
of Hebler and Morse [12] and the extremely sensitivity of AcnB to oxidation [17] made it difficult 
to address this question in the time available, but this remains an interesting phenomenon 
worthy of further study. 
The compensatory mutant LV41C does show a sharp decrease in CFU after entering 
stationary phase whereas the parent strain plateaus, indicating that decrease in OD600 during 
stationary phase associated with the growth phenotype is possibly due to cell lysis instead of 
altered optical characteristics or clumping. Clumping is excluded because the opa genes 
(adhesins that cause clumping) did no show significantly altered expression in the mutants and 
only non-piliated colonies were used (data not shown; experiments performed by Leah Vincent 
and Yang Tan). 
 
3. Post-transcriptional regulation 
There was a clear discrepancy between the levels of AcnB protein and the levels of 
acnB mRNA. The levels of acnB mRNA remained constant in the strains tested from log- and 
stationary-phase cultures, whereas the levels of AcnB protein changed quite dramatically in 
both wild-type and mutant strains as the cells transitioned from log-phase to stationary-phase 
growth. Compared to the wild-type, the mutant strain paradoxically had more overall acnB 
mRNA, but a reduction in the amount of protein produced.  
In E. coli and Helicobacter pylori, AcnB has been reported to act as a post-transcriptional 
regulator of protein production by binding to the UTRs of multiple mRNAs, including its own, and 
altering the translation rates of translation of the bound RNA [21] [22]. These reports hint at a 
possible post-transcriptional mechanism in N. gonorrhoeae that may regulate AcnB protein 
production. Given that aconitase functions as a pleiotropic post-transcriptional regulator in other 
species, it is possible that the aconitase in N. gonorrhoeae is functioning as a post-
transcriptional regulator as well. Although the EMSAs did not indicate binding between the Apo-
AcnB protein and the 3’UTR or 5’UTR of acnB mRNA, it is possible that the optimal reaction 
conditions for this interaction were not used or that AcnB could be altering the production of 
itself indirectly through the regulation of other transcripts. With regards to the former possibility, 
binding conditions similar to those used by Tang and Guest [21] and Austin et al. [22] were also 
used and did not have any observable shifts in motility for the combinations of RNA and AcnB 
tested (data not shown). It is also possible that the binding of AcnB protein to other transcripts is 
more important for fitness in the compensatory mutant because approximately 65 genes are 
upregulated more than 2-fold in acnB mutant strains during logarithmic growth on glucose (data 
not shown; experiments performed by Yang Tan).  
 
In conclusion, the mechanism by which the acnB-G348D mutant allele compensates for 
some of the biological fitness cost associated with carrying the mosaic penA41 allele is unclear, 
but it does not appear to be directly related to its function as a TCA cycle enzyme. One 
possibility is that the mutant protein functions as a post-transcriptional regulator, thereby 
regulating production of other proteins and expression of other genes. Indeed, of the 65 genes 
upregulated in strains harboring the acnB-G348D mutant allele at log-phase growth, 2/3 of them 
are in energy production and carbon metabolism, and this upregulation may be sufficient to 
confer a fitness advantage. Moreover, given the constant levels of glucose and lactate present 
in the vaginal tract, infections in the host are unlikely to encounter physiological conditions that 
would trigger entrance into stationary-phase growth where the fitness of the mutant strains 
might be compromised. 
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Figure 1 
In vitro growth curves of the indicated N. gonorrhoeae strains in GCB liquid media with glucose as the carbon source.  In A 
and B only one replicate of FA19 rpsL penA41 acnB-HA is presented, but is representative of the growth phenotype. 
Strains labeled with “-HA” are producing a HA-tagged AcnB. (A, C) Data on a linear scale (B, D) Data on a log10 scale. 
Experiments represented in C, D were performed by Leah Vincent at Uniformed Services University. 
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 Figure 2 
In vitro growth curves of the indicated N. gonorrhoeae strains in GCB liquid 
media with lactate as the carbon source. (A) OD600 plotted on a linear scale 
(B) OD600 plotted on a log10 scale 













FA19 rpsL penA41 acnB-G348D








































Glucose concentration in the media during in vitro growth of indicated N. gonorrhoeae 
strains in GCB liquid media with glucose as the carbon source. The grey marker 
indicates the approximate transition from lag to log phase and the black marker 
indicates the approximate transition from log to stationary phase. Only one replicate 
of LV41C is displayed. Four replicates of FA19 rpsL and three replicates FA19 rpsL 





Relative abundance of AcnB in the indicated N. gonorrhoeae strains at the 
beginning of logarithmic growth in vitro (t=2 hr) using liquid GCB media with 































































































ns   Not Significant
*   p < 0.05






























 protein abundance at t=2 hr is 1)
FA19 rpsL acnB-WT-HA (OD600)
FA19 rpsL acnB-WT-HA Relative AcnB Abundance 
FA19 rpsL acnB-G348D-HA (OD600)
FA19 rpsL acnB-G348D-HA Relative AcnB Abundance 
Figure 5 
Growth curves and relative abundance of AcnB protein in two strains of N. gonorrhoeae 
during in vitro growth in liquid GCB media. Abundance is relative to the amount of 
protein present at the beginning of logarithmic growth (t=2 hr). Black marker indicates 
the transition from log to stationary phase for FA19 rpsL acnB-HA. Grey marker 
indicates the transition from log to stationary phase for FA19 rpsL acnB-G348D-HA. 

























































































 ) Log Phase (t=2, 3 hr)
Stationary Phase (t=7, 8 hr))
***
*** p < 0.001 
**
**  p < 0.01 
****
**** p < 0.0001 
Figure 6 
Comparative abundance of AcnB protein in stationary and log phases of growth in 
indicated N. gonorrhoeae strains during in vitro growth in liquid GCB media 
containing glucose as the carbon source. Abundance is relative to the amount of 
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FA19 rpsL Relative acnB mRNA Expression
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Figure 7 
Expression of acnB mRNA in strains carrying the acnB wild-type allele. Expression is 
relative to the amount of mRNA at the beginning of logarithmic growth (t=2 hr). The black 
marker indicates the transition from log to stationary phase. Error bars for RNA 
expression represent the 95% CI. The left y-axis is on a log10 scale and the right y-axis is 









Expression of acnB mRNA in strains carrying the acnB-G348D allele. Expression is 
relative to the amount of mRNA at the beginning of logarithmic growth (t=2 hr). The 
black marker indicates the transition from log to stationary phase. Error bars for RNA 
expression represent the 95% CI. The left y-axis is on a log10 scale and the right y-
axis is on a log2 scale. 
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FA19 rpsL acnB-G348D Relative acnB mRNA Expression
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Fold Change In acnB  mRNA Expression (2-∆∆Ct) 
Figure 9 
Expression of acnB mRNA in FA19 rpsL acnB-G348D relative to acnB mRNA in strains with 
the wild-type acnB allele during in vitro growth in liquid GCB media containing glucose as the 
carbon source. Error bars for RNA expression represent the 95% CI. The left y-axis is on a 














Aconitase activity assay of mutant and WT AcnB proteins using purified, cloned proteins. 
Data generated by Josh Tomberg. 



























































Aconitase activity per mg of soluble protein present in different preparations of cell lysates. 
One unit of aconitase activity is defined as the formation of one µmole of NADPH per minute 
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EMSA of N. gonorrhoeae acnB mRNA 5’UTR and Apo-AcnB protein. Lane 1 and 10 
are dsDNA standards and a Page Ruler Plus Prestained protein ladder, respectively. 
Lanes 2-8 have 70ng acnB 5’UTR RNA. Lanes 3-8 have increasing amounts of Apo-
AcnB protein starting with 25ng and doubling every lane to 800ng protein in lane 8. 
Lane 9 has only Apo-AcnB protein (800ng). The fainter lower protein band in lanes 2-
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Figure 13 
EMSA of N. gonorrhoeae acnB mRNA extended 3’UTR with Apo-AcnB protein and the 
positive control from P. aeruginosa (tssa1 RNA and RsmA protein). Lane 1 and 10 are 
dsDNA standards and a Page Ruler Plus Prestained protein ladder, respectively. Lane 2: 
70ng tssa1 RNA only. Lane 3: 70 ng tssa1 RNA and 100 ng RsmA. Lane 4: 70ng tssa1 RNA 
and 800 ng RsmA. Lane 5: 800ng RsmA protein only. Lane 6: 70ng acnB extended 3’UTR 
RNA only. Lane 7: 70ng acnB extended 3’UTR RNA and 100ng Apo-AcnB protein. Lane 8: 
70ng acnB extended 3’UTR RNA and 800ng Apo-AcnB protein. Lane 9: 800ng Apo-AcnB 
protein only. (A) Overlay of nucleic acid stain (B) and protein stain (C). The misshapen lane 
5 is thought to be from a bubble in the electrophoresis apparatus. 
 











Oligos used for the amplification of segments of 16S rRNA and acnB mRNA in qPCR 
Oligo Name Sequence 
5’ 16S 1325 GTGCATGAAGTCGGAATCGC 
3’ 16S 1451 GCGGTTACCCTACCTACTTCTG 
5’ acnB 1340 CTGCCTATCCGAAACCTGTCG 
3’ acnB 1491 GCCGCCTGTACCGACTGTATC 
